Gordon KB, Langley RG, Warren RB, Okubo Y, Rosmarin D, Lebwohl M, Peterson L, Madden C, de Cuyper D, Gomez NN, Thaçi D. Bimekizumab safety in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in phase 2 and 3 clinical trials. J of Skin [Internet]. 2022Nov.16 [cited 2024Jul.22];6(6):s66. Available from: https://jofskin.org/index.php/skin/article/view/1821